Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hillenbrand, Inc.
Hillenbrand Expects to Report Second-Quarter Net Revenue of $170.8 Million and Revises 2009 Guidance
April 26th, 2009
Hillenbrand, Inc. (NYSE:HI) is revising its 2009 guidance, based on lower-than-expected revenue of $170.8 million during its second fiscal quarter. For the full 2009 fiscal year, the company expects revenues to range from $650 million to $670 million, a reduction of approximately 6 percent from previous revenue guidance. In addition, GAAP diluted earnings per share have been adjusted upward to a range of $1.57 to $1.70, reflecting an increase of approximately 2 percent from prior guidance. "Our business is dependent on the seasonal effects on burials, and the decline we've seen is consistent with public reports from our customers and competitors," said Kenneth A. Camp,...
Source: Pharma Investments, Ventures & Law Weekly (2009-04-26)
|
